BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28817072)

  • 1. Efficient Transdermal Delivery of Alendronate, a Nitrogen-Containing Bisphosphonate, Using Tip-Loaded Self-Dissolving Microneedle Arrays for the Treatment of Osteoporosis.
    Katsumi H; Tanaka Y; Hitomi K; Liu S; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28817072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel self-dissolving microneedle array of alendronate, a nitrogen-containing bisphosphonate: evaluation of transdermal absorption, safety, and pharmacological effects after application in rats.
    Katsumi H; Liu S; Tanaka Y; Hitomi K; Hayashi R; Hirai Y; Kusamori K; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Pharm Sci; 2012 Sep; 101(9):3230-8. PubMed ID: 22467424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34).
    Naito C; Katsumi H; Suzuki T; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30400376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
    Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Phosphoric Acid-Mediated Hyaluronic Acid Gel Sheet for Efficient Transdermal Delivery of Alendronate for Anti-Osteoporotic Therapy.
    Naito C; Katsumi H; Yoneto K; Omura M; Nishidono M; Kamei S; Mizoguchi A; Tamba A; Tanaka A; Morishita M; Yamamoto A
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31810310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a novel transdermal delivery system of alendronate, a nitrogen containing bisphosphonate, using a new type of hydrophilic patch and dissolving microneedle arrays].
    Katsumi H
    Yakugaku Zasshi; 2014; 134(3):427-31. PubMed ID: 24584024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of Transdermal Delivery of Exendin-4 Using Novel Tip-Loaded Microneedle Arrays Fabricated from Hyaluronic Acid.
    Liu S; Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Mol Pharm; 2016 Jan; 13(1):272-9. PubMed ID: 26649921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeation of sumatriptan succinate across human skin using multiple types of self-dissolving microneedle arrays fabricated from sodium hyaluronate.
    Wu D; Katsumi H; Quan YS; Kamiyama F; Kusamori K; Sakane T; Yamamoto A
    J Drug Target; 2016 Sep; 24(8):752-8. PubMed ID: 26878569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levothyroxine sodium loaded dissolving microneedle arrays for transdermal delivery.
    Ghazi RF; Al-Mayahy MH
    ADMET DMPK; 2022; 10(3):213-230. PubMed ID: 36131889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery.
    Pamornpathomkul B; Ngawhirunpat T; Tekko IA; Vora L; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2018 Aug; 121():200-209. PubMed ID: 29777854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication and Characterization of Dissolving Microneedles for Transdermal Drug Delivery of Apomorphine Hydrochloride in Parkinson's Disease.
    Ando D; Ozawa A; Sakaue M; Yamamoto E; Miyazaki T; Sato Y; Koide T; Izutsu KI
    Pharm Res; 2024 Jan; 41(1):153-163. PubMed ID: 37923948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery.
    Zhuang J; Rao F; Wu D; Huang Y; Xu H; Gao W; Zhang J; Sun J
    Eur J Pharm Biopharm; 2020 Dec; 157():66-73. PubMed ID: 33059004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays.
    Garland MJ; Migalska K; Tuan-Mahmood TM; Raghu Raj Singh T; Majithija R; Caffarel-Salvador E; McCrudden CM; McCarthy HO; David Woolfson A; Donnelly RF
    Int J Pharm; 2012 Sep; 434(1-2):80-9. PubMed ID: 22669101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel transdermal patch of alendronate, a nitrogen-containing bisphosphonate, for the treatment of osteoporosis.
    Kusamori K; Katsumi H; Abe M; Ueda A; Sakai R; Hayashi R; Hirai Y; Quan YS; Kamiyama F; Sakane T; Yamamoto A
    J Bone Miner Res; 2010 Dec; 25(12):2582-91. PubMed ID: 20533374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolving Polymer Microneedles for Transdermal Delivery of Insulin.
    Zhang N; Zhou X; Liu L; Zhao L; Xie H; Yang Z
    Front Pharmacol; 2021; 12():719905. PubMed ID: 34630098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing intradermal delivery of tofacitinib citrate: Comparison between powder-loaded hollow microneedle arrays and dissolving microneedle arrays.
    Cárcamo-Martínez Á; Mallon B; Anjani QK; Domínguez-Robles J; Utomo E; Vora LK; Tekko IA; Larrañeta E; Donnelly RF
    Int J Pharm; 2021 Jan; 593():120152. PubMed ID: 33301867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: Potential for enhanced treatment of psoriasis.
    Tekko IA; Permana AD; Vora L; Hatahet T; McCarthy HO; Donnelly RF
    Eur J Pharm Sci; 2020 Sep; 152():105469. PubMed ID: 32679177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing difficulties and instability of carbohydrate microneedle arrays.
    Donnelly RF; Morrow DI; Singh TR; Migalska K; McCarron PA; O'Mahony C; Woolfson AD
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1242-54. PubMed ID: 19555249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.